Results
Orchid Pharma Posts Revised FY26 Results Post-Merger
Orchid Pharma revised its audited standalone and consolidated FY26 financial results to incorporate the NCLT-sanctioned merger with Dhanuka Laboratories, effective from April 1, 2024.
Standalone net p
